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ABSTRACT 
Objectives: To pilot the methods for a randomized controlled trial (RCT) to investigate 
whether the treatment effect of Mechanical Diagnosis and Therapy (MDT) is enhanced 
with the LUMOback. 
Design: Assessor blinded RCT with 3 and 6-week follow-ups. 
Setting: An outpatient clinic. 
Participants: Primary eligibility criteria were: a directional preference of lumbar 
extension, ≥18 years of age, and non-specific low back pain lasting for ≥1 month. 
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Interventions: The MDT group undertook extension exercises (10 reps/3h) and 
postural correction using a lumbar roll at home. The MDT+LUMOback group also wore 
the LUMOback daily, providing a vibration alert in a slouched posture. 
Main outcome measures: The Global Rating of Change Scale (GRCS) (0-6), 
recruitment rate per month, treatment sessions, compliance rate of wearing the 
LUMOback, participants’ adherence with treatment, dropout rate and the stage of the 
MDT program at six weeks. 
Results: Twenty-two participants were included for 20 months (a recruitment rate of 
1.1 patients/month). Dropout rate was 9%. The mean (SD) of the GRCS of the MDT 
and MDT+LUMOback groups were 4.7 (0.8) and 4.7 (0.5) at the 3-week follow-up and 
were both 4.9 (0.5) at the 6-week follow-up. The patients undertook a mean of 6.7 
sessions for six weeks and exercises with mean of 3.7 set/day in each group. The 
mean compliance rate of wearing the LUMOback was 88%. Nobody was discharged 
from the intervention with full recovery within six weeks. 
Conclusions: Data indicated a promising method for the full RCT, but a rationale for 
the full RCT was not justified.  
 
Clinical Trial Registration number: UMIN000018380 
Contribution of paper 
 It was the ultimate aim to investigate if the treatment effect of Mechanical 
Diagnosis and Therapy (MDT) could be enhanced with the use of real-time 
feedback with the LUMOback in patients with a directional preference of lumbar 
extension. 
 Regarding the methodology to achieve that aim, recruitment of participants in 
multiple centers was considered necessary, because of the low recruitment rate in 
the current study. 
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 However, further investigation in a multi-center trial using the current methods is 
not justified due to the lack of difference in the treatment effect of MDT within six 
weeks, with or without the use of the LUMOback for assisting postural correction.  
 
Keywords: back pain; exercise therapy; lumbosacral region; manipulative therapies; 
posture; proprioceptive feedback 
 
 
BACKGROUND 
Low back pain (LBP) results in economic and healthcare burden throughout the 
world [1]. In patients with acute LBP (i.e. symptom duration <1 month), moderate-
quality evidence showed no clear differences between different exercise regimes [2]. 
However, the following are also recommended with strong-evidence [3]: mechanical 
loading strategies in a specific direction resulting in centralization to be undertaken in 
patients with LBP with related (referred) lower extremity pain including acute LBP; and 
mechanical loading strategies in a specific direction resulting in improvement of 
symptoms and mobility of the back to be undertaken in patients with acute, subacute 
or chronic LBP. The specific direction resulting in centralization and/or improvement of 
symptoms and mobility is termed directional preference (DP). Therefore, exercise 
therapy with mechanical loading strategies in the DP is an evidence-based approach 
for all patients with LBP with or without referred pain.    
A previous study suggested that individuals with LBP had more slouched 
habitual lumbopelvic posture than individuals without any history of LBP [4]. 
Furthermore, an awkward posture, such as slouched posture, is a risk factor for LBP, 
and the risk increases when this posture is combined with prolonged sitting [5]. 
Therefore, postural correction/education to maintain the lumbar lordosis is likely to be 
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important to enhance the treatment effect of exercise therapy in the DP, particularly for 
patients who have LBP with or without referred pain and a DP of lumbar extension.  
Mechanical Diagnosis and Therapy (MDT) is one of the most commonly used 
physical therapy approaches for the management of LBP [6, 7], which includes a 
biopsychosocial perspective [8] and puts an emphasis on patient education [9]. In 
patients with a DP for extension, MDT includes exercise therapy in the DP, such as 
extension in lying, and postural correction/education using a lumbar roll to avoid 
kyphotic lumbar posture with posterior pelvic tilt. Recent developments in wearable 
device technologies may also be useful for postural correction. The LUMOback (Lumo 
Bodytech Inc., Mountain View, CA, USA) device, which works on i-phone application, 
continuously monitors the pelvic position during everyday life and can provide real-
time feedback to avoid a slouched posture using a vibration alert. Therefore, it was 
hypothesized that the treatment effect of MDT could be enhanced with the use of real-
time feedback with the LUMOback in patients with a DP of lumbar extension. However, 
there has been no study using MDT with the LUMOback and it was considered prudent 
to undertake a pilot randomized control trial (RCT) before undertaking a full RCT. 
The purpose of this study was to pilot the methods proposed to conduct a full 
RCT to investigate whether the treatment effect of MDT is enhanced with the 
LUMOback in patients with LBP and a DP of lumbar extension. In particular, the 
following aspects were investigated: 1) recruitment rate per month, 2) number of 
treatment sessions, 3) compliance rate of wearing the LUMOback, 4) adherence with 
treatment, 5) dropout rate and 6) stage of the MDT program at six weeks. The 
secondary purpose was to undertake a preliminary comparison in patient reported-
outcomes and to estimate the variability of these outcomes in this patient population.        
 
METHODS 
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Design 
This study was a single-center assessor blinded parallel group RCT, where one 
group of interventions was MDT only (MDT group) and the other was MDT with real-
time feedback using the LUMOback (MDT+LUMOback group). All patients provided 
written consent before data collection. The study design was approved by the 
institutional research ethics committee (XXXX) and pre-registered in the trial 
registration (UMIN000018380).   
 
Patients 
Patients were recruited via advertising in a local orthopedic clinic in XXX from 
August 2015 to March 2017. Inclusion criteria of participants were: 1) ≥18 years of age, 
2) non-specific LBP diagnosed by an orthopedic surgeon (XX), 3) symptoms lasting 
for more than one month, 4) using a smartphone, 5) undertaking LBP management 
based on MDT only, and 6) with a DP for extension. The following patients were not 
considered eligible: 1) patients with a history of back or lower limb surgery or trauma 
within the past six months, 2) patients with a history of nerve root block within the past 
four weeks, 3) patients with a history of neuropathic pathology such as diabetes or 
polyneuropathy, vascular disease in the lower extremity, systemic disease or 
inflammatory arthropathy, 4) patients with any contraindication to manual therapy 
techniques such as fracture, infection or severe osteoporosis, and 5) individuals who 
could not communicate effectively.  
 
Interventions 
The MDT interventions (20-40 minutes) were undertaken in an orthopedic 
outpatient clinic by one author (XX), who was a credentialed MDT physical therapist, 
with MDT diploma clinical training, which is the highest level of training in the MDT 
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program. In total, the therapist undertook 772 hours of official MDT training [10]. 
At the initial MDT session, a DP of extension was established, for which 
acceptable inter-examiner reliability has been established [11]. The MDT interventions 
were undertaken for six weeks as a systematic review with high-quality studies 
supported the use of exercise interventions including MDT for at least six weeks [12].   
The MDT intervention included postural correction in sitting, which was aided 
using a McKenzie lumbar roll (The Original McKenzie® Lumbar Roll™, OPTP, 
Minneapolis, USA). A lumbar roll was provided to each patient and the patients were 
asked to use the lumbar roll during sitting. For home exercises, patients were 
instructed to undertake 10 repetitions of mechanical loading in the direction of lumbar 
extension every three hours, using various forms of the exercise (Appendix 1), five 
sets per day.  
At follow-ups, trouble shooting in postural correction and exercises including 
progression and adjustment of exercises were undertaken. Manual therapy 
techniques including exercises with therapist’s overpressure and passive posterior-
anterior joint mobilization were used when it was considered that recovery with home 
exercises had reached a plateau. When absence of symptoms lasted for more than 
one week, reproduction of symptom or movement restriction was tested using three 
sets of 10 repetitions of flexion in lying. When neither symptom reproduction nor 
movement restriction occurred from the test, exercises with mechanical loading of 
lumbar flexion was incorporated into the home exercises if patients had limitation of 
lumbar flexion. The limitation may have been due to physical aspects such as adapted 
shortening of the extensor muscles, and/or mental aspects such as fear/anxiety of 
forward bending. In the current study, phases of the MDT interventions were defined 
as: 1) a phase of reducing derangement when there were symptoms; 2) a phase of 
maintaining reduced derangement when absence of symptoms lasted for more than 
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one week; 3) a phase of recovery of function when neither symptom reproduction nor 
movement restriction occurred with flexion in lying and 4) discharge due to full recovery. 
In the MDT+LUMOback group, patients were asked to wear the LUMOback 
daily for the full 6-week of the intervention, except when playing water sports, taking a 
shower or sleeping. Detailed information about the LUMOback is found in a previous 
study [4]. Briefly, a threshold of 'very slouched' was considered clinically relevant in 
the MDT intervention [4] and thus a 'very slouched' posture which lasted for more than 
five seconds triggered feedback with LUMOback vibration.  
 
Outcome measures proposed for the full trial 
The treatment effect was assessed with a 7-point Global Rating of Change 
Scale (GRCS) (0=worse than ever, 1=much worsened, 2=slightly worsened, 3=no 
change, 4=slightly improved, 5=much improved, 6=completely recovered). The GRCS 
were assessed at three and six weeks after the initial MDT session. 
 
Secondary outcome measures 
The current study included demographic and patient-reported measures, and 
objective measures. In the demographic and patient-reported measures, the following 
were assessed: 1) age and gender, 2) symptom information including pain location, 
pain intensity, pain duration, magnitude of disability, self-reporting functional limitations, 
and quality of life. In the objective measures, sagittal mobility of the trunk was 
assessed by a blinded examiner. The pain intensity, magnitude of disability, self-
reporting functional limitations, quality of life and sagittal mobility of the trunk were 
assessed at the initial MDT session and at three and six weeks.  
 
The demographic and patient-reported measures 
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Pain location was assessed with a body chart, in which a higher score indicated 
more distal pain (Appendix 2). The pain intensity was assessed with the P4, where a 
sum score of 0 indicates no pain and that of 40 indicates the highest possible pain 
level. Pain duration was defined as the number of days and/or months since the last 
pain-free month according to a previous recommendation [13]. The magnitude of 
disability was assessed with the Oswestry Disability Index Japanese version, where 
0% indicates no disability and 100% indicates the greatest disability. The self-reported 
functional limitation was assessed with the Patient Specific Functional scale, where 
an average score of 0 indicates the maximum limitation and that of 10 indicates no 
limitation. The quality of life was assessed with the physical component summary 
score, indicating quality of life in physical aspects, and the mental component 
summary score, indicating quality of life in mental aspects, of the 36-Item Short-Form 
Health Survey version 2-week. The value of 50 indicates Japanese normal, and the 
greater the value is, the better the condition is.  
 
The objective measures 
The sagittal mobility of the trunk in standing was assessed with the Finger  
Floor Distance (FFD) [14] and a Modified Schober's Test [15]. In the FFD, positive 
value indicates that the finger reaches above the floor and negative value indicates 
that the finger reaches below the floor. In the Modified Schober's Test, the value of 
15.0cm indicates no movement of lumbar extension, and smaller values indicate 
greater lumbar extension range of motion in standing.  
 
Outcome measures in the pilot trial 
The recruitment rate per month, treatment sessions, and dropout rate were 
recorded. The compliance rate of wearing the LUMOback was defined as the 
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proportion of days with a change of posture score through a day, which was a 
proportion of time in a day with neutral pelvic posture relative to the time with a ‘very 
slouched’ posture. The participants’ adherence with treatment was assessed with an 
exercise diary, where one check was marked when 10 repetitions of the exercise were 
undertaken. The number of sets with 10 repetitions of exercises per day was 
calculated. The MDT program at six weeks was recorded in terms of the four phases 
of the intervention as listed before. 
 
Sample size estimation 
Sandvik et al. [16] recommended using 10 individuals for a pilot study; allowing 
for 10% of dropout, 11 patients were recruited for each group. 
 
Randomization 
Randomization was undertaken using sealed opaque envelopes, with 
concealed allocation maintained as patients selected an envelope with the intervention 
group. Patients were asked not to reveal their intervention group to the examiner for 
the sagittal mobility of the trunk.  
 
Data analysis 
The descriptive analysis was undertaken and mean (SD) or number (%) was 
calculated. For the outcome measures proposed for the full trial, the mean value of the 
GRCS was presented for each group at each follow-up along with the mean difference 
between the groups and its associated 95% confidence intervals (CIs). The mean 
value of the change from baseline to each follow-up and its mean difference between 
the groups with its associated 95% CIs was also calculated using descriptive analyses 
in other outcome measures proposed for the full trial. 
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RESULTS 
Appendix 3 presented a flow-chart of the patients. Twenty-two participants were 
included in randomization over 20 months, and thus the recruitment rate per month 
was 1.1 patients per month. It was also estimated that 2.9 patients need to be 
assessed for eligibility to find one patient to be included in the study. Dropout rate was 
9% at six weeks.  
Table 1 summarized the characteristics of the patients at baseline; and Table 2 
presented the mean values and differences, with 95% CI, between groups at follow-
ups.  
There was nobody who rated the GRCS≤2 in each follow-up. The mean (SD) 
of the GRCS of the MDT group and MDT+LUMOback group were 4.7 (0.8) and 4.7 
(0.5), respectively and its difference (95% CIs) between the groups was 0 (-0.6 to 0.6) 
at the 3-week follow-up. The mean (SD) of the GRCS of the MDT group and 
MDT+LUMOback group were equally 4.9 (0.5) and its difference (95% CIs) between 
the groups was 0 (-0.5 to 0.5) at the 6-week follow-up. Mean changes and differences 
(95% CI) between groups in other outcome measures are presented in Table 2. 
Appendix 4 presented the mean (SD) of the outcome measures proposed for the full 
trial except the GRCS at each follow-up. 
The mean (SD) treatment sessions from the baseline to the 3-week follow-up 
were 4.0 (1.2) sessions in the MDT group and 4.1 (0.8) sessions in the 
MDT+LUMOback group and those from the 3-week follow-up to the 6-week follow-up 
were 2.8 (1.2) sessions and in the MDT group and 2.4 (0.7) sessions in the 
MDT+LUMOback group. The mean (SD) of the number of sets with 10 repetitions of 
exercises per day was 3.7 (1.5) sets per day in the MDT group and 3.7 (1.6) sets per 
day in the MDT+LUMOback group, respectively. There was nobody who did not 
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undertake the exercises at all over three successive days. In the MDT+LUMOback 
group, the mean (SD) compliance rate of wearing the LUMOback was 88% (15%), 
where the mean (SD) posture score was 64% (14%). Table 3 demonstrated the phase 
of the MDT program at six weeks in both groups. 
 
DISCUSSION 
In the current study, the methods proposed to conduct the full RCT were piloted 
in: 1) recruitment rate per month, 2) treatment sessions, 3) compliance rate of wearing 
the LUMOback, 4) participants’ adherence with treatment, 5) dropout rate and 6) MDT 
program at six weeks. It was also undertaken to make a preliminarily comparison of 
patient reported-outcomes between the MDT and MDT+LUMOback group and to 
estimate the variability of these outcomes. 
The compliance rate of wearing the LUMOback was 88%, which indicates high 
compliance rate of the LUMOback. Patients in both groups undertook home exercises 
a mean of 3.7 sets per day. If 100% compliance was defined as 5 sets per day, the 3.7 
sets per day was 74% compliance. Previously compliance rate of home exercise has 
been reported as about 60% [17], with 80-90% rated as good adherence [18]. 
Therefore, home exercise adherence can be considered acceptable. The dropout rate 
was 9%, which is also considered to be acceptable [19]. The MDT program at six 
weeks was mostly at the early phase of reducing derangement and there was nobody 
who was discharged from the intervention. In addition, the mean of the GRCS was 4.7 
in each group. These findings suggest that six weeks would be reasonable as duration 
of the MDT intervention to compare the size of the treatment effect. There was nobody 
who rated the GRCS≤2 in each follow-up, which indicates that the method tested in 
the current study was safe and acceptable to the participants. The mean posture score 
of the MDT+LUMOback group over the 6-week intervention was 64%, which is similar 
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to those without a history of LBP in a previous study [4]. Therefore, it is assumed that 
postural correction had been successfully undertaken in the patients of the 
MDT+LUMOback group. These would all be positive findings of the current methods 
to progress to a full trial.  
In contrast, negative findings of the current method to progress to a full trial 
were also detected. The recruitment rate was 1.1 patients per month, and it was 
estimated that 2.9 patients need to be assessed for eligibility to find one study patient. 
Thus it would be expected that assessment of 180 patients would be required, and the 
recruitment process take five years to include 30 participants in each group. As the 
current pilot study was undertaken in a single orthopedic outpatient clinic with one 
therapist, a multi-center trial would be needed to generate a better recruitment rate. It 
should also be noted that there was not a placebo or no treatment control group, which 
might be unacceptable to those actively seeking treatment. However, a potential 
reason for the limited recruitment rate may be that patients in the current cohort had a  
lack of confidence to manipulate the wearable device.  
A promising method for the full trial has been considered, but preliminarily data 
of the patient reported-outcomes between the MDT and MDT+LUMOback groups 
indicate a need to reconsider undertaking a full trial. All baseline measures did not 
seem comparable. For example, the FFD was not comparable, considering its 
minimum detectable change of 4.5cm [20], which would not be surprising because of 
the small sample size. However, all measures demonstrated negligible mean 
difference between the groups at each follow-up, with 95% CIs that included zero. This 
indicates that any clinically important differences in the treatment effect are not likely 
to be detected between the MDT and MDT+LUMOback groups at least for six weeks. 
Thus, rather than undertaking the full trial, a promising future research agenda may 
be: investigating patients’ preference to keep using the LUMOback for their 
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management of posture; and comparing recurrence rate of LBP between those with 
and without the use of a wearable device to manage habitual posture such as the 
LUMOback using a long-term follow-up. However, there is a lack of consensus about 
whether posture is actually a risk factor for LBP [5, 21, 22].  
 
Limitations 
A limitation of the current study is that current data was contaminated by a self-
selection bias. In particular, using the LUMOback might have been limited to patients 
who had an interest in, and expectations for, physical therapy interventions and 
technologies. It is known that patient expectations influence treatment effect [23], and 
that they are different between placebo-controlled clinical trials and clinical practice 
[24]. The MDT+LUMOback group undertook interventions that were more than normal 
clinical practice, whereas the MDT group undertook interventions that were very close 
to clinical practice. It may be possible that the treatment effect in the current study was 
greater than other studies using MDT without cutting-edge interventions or placebo-
controlled trials. 
Another limitation is that reasons for the lack of group differences in the 
treatment effect are unclear due to the lack of LUMOback data in the MDT group. It 
might be possible that postural correction undertaken in MDT is sufficient to minimize 
habitual posture with lumbar lordosis and posterior pelvic tilt. It might also be possible 
that correction of habitual posture is not as important as undertaking exercises in a DP 
unless habitual posture is extremely impaired. Further studies with monitoring habitual 
lumbopelvic posture before and during the course of the MDT management would be 
required.   
 
CONCLUSION 
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Data of the pilot study provide suggestions for a promising method. However, 
preliminarily data of group comparisons indicate no clinically important difference in 
the treatment effect of MDT within six weeks with or without the use of the LUMOback 
for assisting postural correction. Thus, further investigations in a multi-center trial with 
the current method are not justified.  
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FIGURE LEGENDS 
FIGURE 1. Body chart to assess pain location.  
FIGURE 2. Flow of the participants. 
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TABLE 1. Summary of the patients analyzed in the current study at the initial 
Mechanical Diagnosis and Therapy (MDT) session.  
Abbreviations: MDT group, patients undertook MDT; MDT+LUMOback group, patients 
undertook MDT using real-time postural feedback with the LUMOback; SF-36v2, 36-
Item Short-Form Health Survey version 2. 
aA higher sum score indicated more spreading pain. 
b0 = no pain, 40 = the highest pain intensity. 
cGreater values indicate more severe disability. 
d0 = unable to perform activity, 10 = able to perform activity at the same level as before 
Variables 
MDT group 
(n = 10) 
MDT+LUMOback 
group 
(n = 10) 
Women, number (%) 3 [30%] 5 [50%] 
Age (years) 40.4 (13.8) 41.1 (10.7) 
Pain location (1-41)a 16.8 (10.3) 9.8 (8.3) 
P4 (0-40)b 19.7 (7.8) 18.6 (5.5) 
Pain duration (months) 26.5 (35.9) 24.4 (37.2) 
Oswestry Disability Index (%)c 28.4 (15.8) 29.1 (8.3) 
Patient Specific Functional scale (0-10)d 4.3 (1.5) 4.5 (1.7) 
SF-36v2 physical component summary 
score (national standard value, 50)e 
36.1 (6.5) 40.8 (7.8) 
SF-36v2 mental component summary 
score (national standard value, 50)f 
48.8 (3.8) 47.2 (8.2) 
Figure Floor Distance (cm)g 1.1 (9.5) 12.0 (18.2) 
Lumber extension range of motion (cm)h 12.6 (1.4) 12.8 (0.8) 
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injury or problem. 
e50 = national average, greater values indicate a better condition. 
fPositive value indicates that the finger reaches above the floor and negative value 
indicates that the finger reaches below the floor. 
gmeasured by a Modified Schober's Test [15]: Max = 15.0 cm, smaller values indicate 
grater lumbar extension range of motion in standing.  
Values are presented as mean (SD) or numbers [%]. 
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TABLE 2. The mean (SD) value of the change from baseline to each follow-upa and 
its mean difference between the groups with its associated 95% confidence intervals 
(CIs). 
Variabl
es 
3-week follow-up 6-week follow-up 
(A) 
MDT 
grou
p 
(n = 
10) 
(B) 
MDT+LUMOba
ck group 
(n = 10) 
(A-B) 
Differenc
e 
[95% CIs] 
(A)  
MDT 
group 
(n = 10) 
(B) 
MDT+LUMOba
ck group 
(n = 10) 
(A-B) 
Differenc
e 
[95% CIs] 
P4 (0-
40)b 
-5.1 
(10.6) 
-6.7 (7.7) 
1.6 [-7.6 
to 10.8] 
-10.0 
(10.7) 
-12.1 (6.5) 
2.1 [-6.7 
to 10.9] 
ODI 
(%)c 
-12.4 
(17.3
) 
-10.0 (9.4) 
-2.2 [-
16.1 to 
11.7] 
-17.0 
(19.0) 
-19.6 (9.5) 
2.6 [-
12.3 to 
17.5] 
PSFS 
(0-10)d 
2.4 
(2.1) 
1.9 (3.0)  
0.6 [-2.0 
to 3.2] 
3.6 (2.2) 3.8 (3.0) 
-0.3 [-2.9 
to 2.3] 
PCSe 
4.3 
(10.5) 
1.8 (12.1) 
2.5 [-8.7 
to 13.8] 
13.7 
(13.0) 
13.6 (8.3) 
0 [-10.7 to 
10.8] 
MCSe 
6.0 
(5.8) 
3.7 (6.9) 
2.3 [-4.0 
to 8.6] 
2.6 (8.5) 2.1 (4.0) 
0.4 [-6.1 
to 7.0] 
FFD 
(cm)f 
-2.7 
(4.9) 
-0.6 (6.6) 
-2.2 [-7.9 
to 3.6] 
-2.7 (9.6) -3.3 (11.2) 
0.6 [-9.8 
to 10.9] 
Ex 
ROM 
-0.5 
(0.8) 
-0.6 (1.3) 
0.1 [-0.9 
to 1.1] 
-0.7 (0.9) -1.2 (1.0) 
0.5 [-0.4 
to 1.5] 
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(cm)g 
Abbreviations: MDT, Mechanical Diagnosis and Therapy; MDT group, patients 
undertook MDT; MDT+LUMOback group, patients undertook MDT using real-time 
postural feedback with the LUMOback; ODI, Oswestry Disability Index; PSFS, Patient 
Specific Functional scale; PCS, SF-36v2 physical component summary score; MCS, 
SF-36v2 mental component summary score; FFD, Figure Floor Distance; Ex ROM, 
Lumber extension range of motion.  
a[Value at each follow-up] – [Value at the baseline] 
bA higher sum score indicated more spreading pain. 0 = no pain, 40 = the highest pain 
intensity. 
cGreater values indicate more severe disability. 
d0 = unable to perform activity, 10 = able to perform activity at the same level as before 
injury or problem. 
e50 = national average, greater values indicate a better condition. 
fPositive value indicates that the finger reaches above the floor and negative value 
indicates that the finger reaches below the floor. 
gmeasured by a Modified Schober's Test [15]: Max = 15.0 cm, smaller values indicate 
grater lumbar extension range of motion in standing.  
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TABLE 3. MDT program at six weeks in each group. 
MDT program MDT group 
(n = 10) 
MDT+LUMOback group 
(n = 10) 
Phase of reducing derangement 6 (60%) 7 (70%) 
Phase of maintaining reduced 
derangement 
2 (20%) 1 (10%) 
Phase of recovery of function  2 (20%) 2 (20%) 
Discharge 0 (0%) 0 (0%) 
Values are presented as numbers (%). 
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